“Evaluation of Inflammatory and Biochemical Markers in COVID-19 Patients Treated With Tocilizumab Alone or With the Combination of Tocilizumab and Convalescent Plasma Transfusion”. Annals of Medical Research 29, no. 7 (July 25, 2022): 770–776. Accessed April 4, 2025. http://annalsmedres.org/index.php/aomr/article/view/4231.